SBI Securities
ENVB icon

SBI Securities’s Enveric Biosciences ENVB Stock Holding History

SBI Securities’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.59K Buy
3,089
+413
+15% +$597 ﹤0.01% 2236
2026
Q2 		$3.69K Buy
2,676
+2,593
+3,124% +$6.23K ﹤0.01% 2318
2026
Q1 		$161 Buy
83
+34
+69% +$93 ﹤0.01% 3289
2025
Q4 		$178 Sell
49
-1
-2% -$7 ﹤0.01% 3246
2025
Q3 		$384 Hold
50
– – ﹤0.01% 3076
2025
Q2 		$726 Sell
50
-10
-17% -$152 ﹤0.01% 2816
2025
Q1 		$1.01K Buy
+60
New +$2.08K ﹤0.01% 2581
2024
Q4 		– Hold
0
– – – 3962

Other funds holding ENVB

AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

SBI Securities's ENVB Position: Q3 2026 in Review

SBI Securities increased its Enveric Biosciences (ENVB) stake by 15% in Q3 2026, buying an estimated $597 and bringing the position to 3,089 shares worth $4.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

SBI Securities first reported a position in ENVB in Q1 2025 and has held it in 7 quarters since. 10 funds tracked by Wall St. Rank hold ENVB as of Q3 2026.

  • SBI Securities held 3,089 shares of Enveric Biosciences worth $4.59K as of Q3 2026.
  • SBI Securities bought 413 Enveric Biosciences shares in Q3 2026, an estimated $597.
  • Enveric Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2236 holding.
  • SBI Securities first reported a position in Enveric Biosciences in Q1 2025 and has held it in 7 quarters since.
  • 10 funds tracked by Wall St. Rank held Enveric Biosciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.